Literature DB >> 1569338

Interleukin-6 and its relationship to C-reactive protein and fever in children with febrile neutropenia.

D Heney1, I J Lewis, S W Evans, R Banks, C C Bailey, J T Whicher.   

Abstract

The assessment of febrile neutropenia is problematic. C-reactive protein (CRP) values alone do not differentiate those patients with microbiologically documented infections from those with unexplained fevers. Plasma interleukin-6 (IL-6), measured by ELISA, was correlated with different diagnostic groups in 47 episodes of febrile neutropenia in children. Samples were collected daily from admission until resolution of fever. On admission, the median IL-6 value for gram-negative infections was 1610 pg/ml (range, 896-40,000), for gram-positive infections it was 138 pg/ml (range, 66-1045), and for unexplained fevers it was 50 pg/ml (range, 24-135, with a single high value of 665 pg/ml). These medians were significantly different (P less than .005). There was no significant difference in median CRP values. IL-6 values peaked 24-48 h before CRP values. There was a positive correlation of IL-6 with the presence of fever. Plasma IL-6 may be a more sensitive marker than CRP of acute infection and should prove useful in the assessment of fevers in these patients.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1569338     DOI: 10.1093/infdis/165.5.886

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  23 in total

1.  Endotoxemia in febrile patients with hematological malignancies. Relationship of type of bacteremia, clinical findings and serum cytokine pattern.

Authors:  P Engervall; M Granström; B Andersson; M Kalin; M Björkholm
Journal:  Infection       Date:  1997 Jan-Feb       Impact factor: 3.553

2.  Diagnostic accuracy of lipopolysaccharide-binding protein for predicting bacteremia/clinical sepsis in children with febrile neutropenia: comparison with interleukin-6, procalcitonin, and C-reactive protein.

Authors:  Lidija Kitanovski; Janez Jazbec; Sergej Hojker; Metka Derganc
Journal:  Support Care Cancer       Date:  2013-09-21       Impact factor: 3.603

3.  An analysis of interleukin-8, interleukin-6 and C-reactive protein serum concentrations to predict fever, gram-negative bacteremia and complicated infection in neutropenic cancer patients.

Authors:  A Engel; E Mack; P Kern; W V Kern
Journal:  Infection       Date:  1998 Jul-Aug       Impact factor: 3.553

4.  Endothelial cells are main producers of interleukin 8 through Toll-like receptor 2 and 4 signaling during bacterial infection in leukopenic cancer patients.

Authors:  C S M Oude Nijhuis; E Vellenga; S M G J Daenen; W A Kamps; E S J M De Bont
Journal:  Clin Diagn Lab Immunol       Date:  2003-07

5.  Cytokines in nasopharyngeal secretions; evidence for defective IL-1 beta production in children with recurrent episodes of acute otitis media.

Authors:  K Lindberg; B Rynnel-Dagöö; K G Sundqvist
Journal:  Clin Exp Immunol       Date:  1994-09       Impact factor: 4.330

Review 6.  Elucidating the unexplained underperformance syndrome in endurance athletes : the interleukin-6 hypothesis.

Authors:  Paula Robson
Journal:  Sports Med       Date:  2003       Impact factor: 11.136

7.  Cytokine concentrations are not predictive of bacteremia in febrile neutropenic patients.

Authors:  Nuray Buyukberber; Süleyman Buyukberber; Alper Sevinc; Celalettin Camci
Journal:  Med Oncol       Date:  2008-08-07       Impact factor: 3.064

8.  Procalcitonin-a sensitive inflammation marker of febrile episodes in neutropenic children with cancer.

Authors:  G Fleischhack; D Cipic; J Juettner; C Hasan; U Bode
Journal:  Intensive Care Med       Date:  2000-03       Impact factor: 17.440

9.  Procalcitonin (PCT) in patients with abdominal sepsis.

Authors:  H B Reith; U Mittelkötter; R Wagner; A Thiede
Journal:  Intensive Care Med       Date:  2000-03       Impact factor: 17.440

10.  Kinetics and correlation with body temperature of circulating interleukin-6, interleukin-8, tumor necrosis factor alpha and interleukin-1 beta in patients with fever and neutropenia.

Authors:  A Engel; W V Kern; G Mürdter; P Kern
Journal:  Infection       Date:  1994 May-Jun       Impact factor: 3.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.